ArticleCarcinogenesis2011

Muscarinic receptor subtype-3 gene ablation and scopolamine butylbromide treatment attenuate small intestinal neoplasia in Apcmin/+ mice.

Jean-Pierre Raufman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.